Clinical Trials for Mesothelioma Patients: Pemetrexed, Cisplatin, and Vitamin B12 Therapy Criteria
Read about the therapy criteria for a current clinical trial being conducted to study the effects of Pemetrexed, Cisplatin, and Vitamin B12 for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, this study is only being conducted in Lille, France.
Prior Concurrent Therapy:
Inclusion criteria:
• At least 28 days since prior radiotherapy (21 days for injected radiotherapy)Exclusion criteria:
• Prior chemotherapy
• Prior yellow fever vaccine
• Inability to discontinue aspirin (> 1.3 g/day) or NSAIDs for 2 days prior to, during, and 2 days after day 1 of each course of study therapy
• Concurrent participation in another clinical study.
Other helpful links:
Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung
cancer
Mesothelioma attorney Mesothelioma
attorney
Mesothelioma Lawyer
Mesothelioma lawyer
Asbestos attorney Asbestos attorney

Contact info for clinical trial of Pemetrexed on mesothelioma patients